AAAAAA

   
Results: 1-8 |
Results: 8
A PHASE-I STUDY OF SUSTAINED-DURATION FILGRASTIM IN NORMAL VOLUNTEERS
Authors: SCHWAB G ROSKOS L MOLINEUX G BRIDDELL R YANG BB CHEUNG E MILLIERMESSANA M LOCKBAUM P GARDNER S HUNT T
Citation: G. Schwab et al., A PHASE-I STUDY OF SUSTAINED-DURATION FILGRASTIM IN NORMAL VOLUNTEERS, Experimental hematology, 26(8), 1998, pp. 95-95
EFFECTIVE AND EFFICIENT PLATELET TRANSFUSION STRATEGIES THAT MAINTAINHEMOSTATIC PROTECTION
Authors: HARKER LA ROSKOS L CHEUNG E
Citation: La. Harker et al., EFFECTIVE AND EFFICIENT PLATELET TRANSFUSION STRATEGIES THAT MAINTAINHEMOSTATIC PROTECTION, Transfusion, 38(7), 1998, pp. 619-621
EFFECT OF A SINGLE-DOSE OF PEGYLATED HUMAN RECOMBINANT MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF) ON PLATELET COUNTS - IMPLICATIONS FOR PLATELET APHERESIS
Authors: TOMITA D PETRARCA M PAINE T OLSON K ROSKOS L CHEUNG E KISICKI J
Citation: D. Tomita et al., EFFECT OF A SINGLE-DOSE OF PEGYLATED HUMAN RECOMBINANT MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF) ON PLATELET COUNTS - IMPLICATIONS FOR PLATELET APHERESIS, Transfusion, 37(9), 1997, pp. 8-8
A CYTOKINETIC MODEL OF PLATELET (PLT) PRODUCTION AND DESTRUCTION FOLLOWING ADMINISTRATION OF PEG-RHUMGDF
Authors: ROSKOS L STEAD R HARKER L CEBON J BASSER R BEGLEY G FARESE A MCVITTIE T TOMITA D PAINE T CHEUNG E
Citation: L. Roskos et al., A CYTOKINETIC MODEL OF PLATELET (PLT) PRODUCTION AND DESTRUCTION FOLLOWING ADMINISTRATION OF PEG-RHUMGDF, Blood, 90(10), 1997, pp. 755-755
PHARMACODYNAMICS OF PEGYLATED MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR FROM A PHASE-I STUDY - EFFECTS OF PLATELET COUNT ON SERUM LEVELS AND CLEARANCE
Authors: DEBOER R FOX S HOPKINS W CASPER L CHEUNG E ROSKOS L BASSER R CEBON J
Citation: R. Deboer et al., PHARMACODYNAMICS OF PEGYLATED MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR FROM A PHASE-I STUDY - EFFECTS OF PLATELET COUNT ON SERUM LEVELS AND CLEARANCE, Experimental hematology, 24(9), 1996, pp. 744-744
THE PROLONGED HEMATOLOGIC EFFECTS OF A SINGLE INJECTION OF PEG-RHUMGDF IN NORMAL AND THROMBOCYTOPENIC MICE
Authors: ULICH TR CASTILLO JD CHEUNG E ROSKOS L YOUNG J MOLINEUX G SENALDI G GUO J TOOMBS CF KAUFMAN S YIN S NELSON AG SHERIDAN WP
Citation: Tr. Ulich et al., THE PROLONGED HEMATOLOGIC EFFECTS OF A SINGLE INJECTION OF PEG-RHUMGDF IN NORMAL AND THROMBOCYTOPENIC MICE, Blood, 88(10), 1996, pp. 1399-1399
HEMATOPOIETIC RECOVERY FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION EFFECT OF PRETREATMENT AND OR THERAPEUTIC ADMINISTRATION OF PEG-RHUMGDF/
Authors: FARESE AM STEAD RB ROSKOS L LIND LB CHEUNG E VIGNEULLE RM RITCHEY B MACVITTIE TJ
Citation: Am. Farese et al., HEMATOPOIETIC RECOVERY FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION EFFECT OF PRETREATMENT AND OR THERAPEUTIC ADMINISTRATION OF PEG-RHUMGDF/, Blood, 88(10), 1996, pp. 2389-2389
EFFECT OF FLUOXETINE, NORFLUOXETINE, SERTRALINE AND DESMETHYL SERTRALINE ON HUMAN CYP3A CATALYZED 1'-HYDROXY MIDAZOLAM FORMATION IN-VITRO
Authors: RING BJ BINKLEY SN ROSKOS L WRIGHTON SA
Citation: Bj. Ring et al., EFFECT OF FLUOXETINE, NORFLUOXETINE, SERTRALINE AND DESMETHYL SERTRALINE ON HUMAN CYP3A CATALYZED 1'-HYDROXY MIDAZOLAM FORMATION IN-VITRO, The Journal of pharmacology and experimental therapeutics, 275(3), 1995, pp. 1131-1135
Risultati: 1-8 |